SciELO - Scientific Electronic Library Online

 
vol.38 número3Deep brain stimulation of the internal globus pallidus in myoclonus-dystonia syndrome: a case series and review of the literatureTetanus as a seizure crisis simulator in a 70-year-old patient, case report índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Acta Neurológica Colombiana

versão impressa ISSN 0120-8748versão On-line ISSN 2422-4022

Resumo

MORENO VARGAS, Eder A. et al. Cost analysis of in hospital attention in a non-valvular atrial fibrillation patient and recurrent stroke. Acta Neurol Colomb. [online]. 2022, vol.38, n.3, pp.139-147.  Epub 22-Out-2022. ISSN 0120-8748.  https://doi.org/10.22379/24224022419.

INTRODUCTION:

A 71-year-old patient with a diagnosis of atrial fibrillation and recurrent strokes, treated with various anticoagulants, the stroke treatment in Colombia for 2008 was $ 450 billion Colombian pesos.

OBJECTIVE:

To estimate the hospital cost of caring for a patient with recurrent stroke secondary to atrial fibrillation.

METHODS:

Partial economic study of micro costing of in-hospital care for a case of recurrent severe spectrum stroke, which does not necessarily reflect the average case. Resource consumption was valued using national reference rates. The results are presented in current 2019 prices (Colombian pesos and US dollars).

RESULTS:

Patient with 3 hospital events, who was hospitalized for 31 days. Hospitalizations had costs of $ 53,883,490 (USD 16,141.1), $ 6,343,096 (USD 1,900.1) and $ 15,719,443 (USD 4,708.9) respectively, with an average price for each hospitalization of $ 25,315,343 (USD 7,583.4), total cost of $ 75,946,029 (USD 22,750.1) daily cost of $ 2,449,872 (USD 729.5). The item that consistently increased costs was procedures (35.7 %).

CONCLUSIONS:

Recurrent stroke caused by nonvalvular atrial fibrillation is associated with a significant increase in direct costs, with an impact of almost twice the GDP per capita. A timely diagnosis and proper selection can reduce it.

Palavras-chave : Stroke; Atrial fibrillation; Costs and cost analysis; Anticoagulants; Economics, medical (MeSH).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )